Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification

Archives of Ophthalmology
Sanket U ShahCarol L Shields

Abstract

To evaluate the efficacy of topical interferon alfa-2b in the management of ocular surface squamous neoplasia (OSSN). Clinically visible OSSN in 20 patients (23 tumors) was managed with topical interferon alfa-2b, 1 million IU/mL, 4 times daily. Tumor control and complications were evaluated according to American Joint Committee on Cancer classification. Complete tumor resolution was achieved in 19 tumors (83%) following topical interferon alfa-2b treatment for a median period of 6 months (mean, 7 months; range, 1-12 months) and maintained for up to 24 months of follow-up. Of the 4 tumors with partial resolution (17%), tumor surface area was reduced 44% (median) during 4 months (median) without further response and alternative therapy was used. Based on American Joint Committee on Cancer classification, complete control was achieved in 2 of 3 Tis (67%), 17 of 20 T3 (85%), 19 of 23 N0 (83%), and 19 of 23 M0 (83%) category tumors. Tumors involving the cornea responded earlier compared with those without corneal involvement (P = .01). Initial tumor size did not correlate with time to response (P = .27). Recurrence was noted in 1 case (Tis, 4%) at 3 months. Adverse effects included conjunctival hyperemia (2 [10%]), follicular hyper...Continue Reading

Citations

Jun 27, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Leyla Asena, Dilek Dursun Altınörs
Jul 7, 2016·Indian Journal of Ophthalmology·Erick Hernandez-BogantesEnrique O Graue-Hernández
May 17, 2017·Ophthalmic Plastic and Reconstructive Surgery·Catherine J ChoiSuzanne K Freitag
Jun 5, 2018·Cornea·Claudine BelleriveArun D Singh
Aug 30, 2018·Clinical & Experimental Ophthalmology·Ashley PolskiJesse L Berry
May 18, 2013·Current Opinion in Ophthalmology·Afshan A NanjiCarol L Karp
Dec 2, 2014·International Ophthalmology Clinics·Jacob Pe'er
Sep 9, 2017·International Ophthalmology Clinics·Rohini RaoJames Chodosh
Nov 14, 2014·Cornea·Mausam R DamaniStephen E Orlin
Sep 26, 2013·The British Journal of Ophthalmology·Anu MaudgilHardeep Singh Mudhar
Dec 13, 2016·The British Journal of Ophthalmology·Raffaele ParrozzaniEdoardo Midena
Aug 17, 2019·Eye and Vision·Ghada Al BayyatCarol L Karp
Jul 16, 2015·Asia-Pacific Journal of Ophthalmology·Rakhi KusumeshRajiv Kumar
Sep 24, 2016·Cornea·Kim Vieira KayatMauro Ajaj Saieg
Apr 12, 2017·Asia-Pacific Journal of Ophthalmology·Carol L ShieldsJerry A Shields
Jul 22, 2018·Ophthalmology and Therapy·Maria Vittoria CicinelliGiulio Modorati
Nov 16, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·N KenawyB E Damato
Feb 11, 2021·Eye·Roland HӧllhumerPamela Michelow
Dec 16, 2018·American Journal of Ophthalmology·Alexandra SantoniJean-Pierre Caujolle
Jun 15, 2021·European Journal of Ophthalmology·Ankush KawaliRohit Shetty
Aug 17, 2021·BMJ Open Ophthalmology·Osmel Peter AlvarezCarol L Karp

❮ Previous
Next ❯

Related Concepts

Related Feeds

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.